Expanded AdvanceBio Portfolio Enables Scientists to Speed Research
and Lower Costs
Agilent Technologies Inc. (NYSE:A) today announced two additions to its
AdvanceBio product family, designed to provide rapid, reproducible
results for scientists in the biopharmaceutical industry.
Agilent introduced the products—the AdvanceBio glycan-mapping workflow
and the AdvanceBio oligonucleotide column—at HPLC 2015, an international
symposium being held in Geneva, Switzerland, this week.
“Both of these new products will help researchers achieve faster, more
reliable separations, lowering their cost per analysis,” said Helen
Stimson, Agilent vice president and general manager of the Chemistries
and Supplies Division. “Like all AdvanceBio solutions, they are designed
to deliver results that are easy to reproduce, increasing confidence in
their accuracy and completeness—vital aspects of biopharmaceutical
development.”
The company’s new AdvanceBio glycan-mapping workflow is a complete
consumables workflow for deglycosylation, 2-AB labeling and HILIC glycan
analysis using mass spectrometry and fluorescence detection. This unique
workflow features AdvanceBio glycan-mapping columns, glycan standards
and N-glycan sample-preparation kits, along with all the consumable
components researchers require.
The product’s comprehensive guides and standard methods provide
researchers with everything they need to quickly identify and quantify
glycans in a way that is easily reproducible.
The new AdvanceBio oligonucleotide column is the first high-pH, stable,
superficially porous particle-based liquid chromatography column for
oligonucleotide analysis. It builds on Agilent’s innovations in
superficially porous silica-based columns for biomolecule separations,
which began with the Poroshell 300 in 2001 and includes AdvanceBio
peptide-mapping, glycan-mapping and RP-mAb columns.
The right particle design gives researchers the flexibility to use
high-performance or ultra-high-performance liquid chromatography
systems. The increased flexibility also allows them to make more
efficient use of existing laboratory resources, thus reducing costs.
AdvanceBio oligonucleotide columns and oligonucleotide standards improve
the reliability of results and reduce costs for therapeutic
oligonucleotide analysis.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences,
diagnostics and applied chemical markets, is the premier laboratory
partner for a better world. Agilent works with customers in more than
100 countries, providing instruments, software, services and consumables
for the entire laboratory workflow. The company generated revenues of
$4.0 billion in fiscal 2014 and employs about 12,000 people worldwide.
Agilent marks its 50th anniversary in analytical
instrumentation this year. Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available at www.agilent.com/go/news.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20150623005380r1&sid=ntxv4&distro=nx&lang=en)
View source version on businesswire.com: http://www.businesswire.com/news/home/20150623005380/en/
Copyright Business Wire 2015